Similar stories
6 outlets
See how this story developed, hour by hour
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.
finance.yahoo.com
19.08.2026
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
time.com
19.08.2026
Moderna’s stock doubles on promising cancer-vaccine results
marketwatch.com
19.08.2026
BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
barrons.com
20.08.2026
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
aljazeera.com
19.08.2026
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
19.08.2026
Related stories
'Moneymaxxing' is the latest personal finance trend. Will it work for you?
‘We got attacked’: Canadians unite in fury against Trump’s latest tariff salvo
CrowdStrike’s stock soars after AI fuels the cybersecurity company’s ‘best quarter’ ever
Nvidia sales more than double to $96bn on bumper AI demand
Salesforce’s stock surges as AI momentum fuels revenue growth
I just had my first baby and don’t want to go back to work. Is quitting for a year a bad idea?